|
Sawa, Akira; Nagata, Eiichiro; Sutcliffe, Siobhan et al. (2005) Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts. Neurobiol Dis 20:267-74
|
|
Nagata, Eiichiro; Sawa, Akira; Ross, Christopher A et al. (2004) Autophagosome-like vacuole formation in Huntington's disease lymphoblasts. Neuroreport 15:1325-8
|
|
Ross, Christopher A; Poirier, Michelle A (2004) Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl:S10-7
|
|
Igarashi, Shuichi; Morita, Hokuto; Bennett, Kyla M et al. (2003) Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation. Neuroreport 14:565-8
|
|
Ozeki, Yuji; Tomoda, Toshifumi; Kleiderlein, John et al. (2003) Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci U S A 100:289-94
|
|
Nucifora Jr, Frederick C; Ellerby, Lisa M; Wellington, Cheryl L et al. (2003) Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity. J Biol Chem 278:13047-55
|
|
Wheeler, Vanessa C; Gutekunst, Claire-Anne; Vrbanac, Vladimir et al. (2002) Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum Mol Genet 11:633-40
|
|
Luthi-Carter, Ruth; Strand, Andrew D; Hanson, Sarah A et al. (2002) Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum Mol Genet 11:1927-37
|
|
Peters, M F; Ross, C A (2001) Isolation of a 40-kDa Huntingtin-associated protein. J Biol Chem 276:3188-94
|
|
Nucifora Jr, F C; Sasaki, M; Peters, M F et al. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291:2423-8
|
Showing the most recent 10 out of 26 publications
